Processes for preparing anhydrous and hydrate forms of...

Details Processes for preparing anhydrous and hydrate forms of... Processes for preparing anhydrous and hydrate forms of...

2006-11-21

2006-11-21

Chang, Celia (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S317000

Reexamination Certificate

active

07138524

ABSTRACT:
The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulaswhich are useful as antihistamines, antiallergic agents and bronchodilators.

REFERENCES:
patent: 3448152 (1969-06-01), Milligan et al.
patent: 3862173 (1975-01-01), Carr
patent: 3878217 (1975-04-01), Carr
patent: 3965257 (1976-06-01), Carr
patent: 4254129 (1981-03-01), Carr
patent: 4254130 (1981-03-01), Carr
patent: 4285957 (1981-08-01), Carr
patent: 4285958 (1981-08-01), Carr
patent: 4672133 (1987-06-01), Crookes
patent: 4742175 (1988-05-01), Fawcett
patent: 5204249 (1993-04-01), Schwartz
patent: 5308840 (1994-05-01), Sugiyama
patent: 5375693 (1994-12-01), Woosley
patent: 5574045 (1996-11-01), Ortyl
patent: 5576610 (1996-11-01), Patino
patent: 5578610 (1996-11-01), D'Ambra
patent: 5581011 (1996-12-01), D'Ambra
patent: 5631375 (1997-05-01), King
patent: 5738872 (1998-04-01), Ortyl
patent: 5750703 (1998-05-01), D'Ambra
patent: 5855912 (1999-01-01), Ortyl
patent: 5932247 (1999-08-01), Ortyl
patent: 6037353 (2000-03-01), Woodward
patent: 6039974 (2000-03-01), MacLaren
patent: 6113942 (2000-09-01), Ortyl
patent: 6147216 (2000-11-01), Krauss
patent: 6187791 (2001-02-01), Woodward
patent: 6242606 (2001-06-01), Krauss
patent: 6399632 (2002-06-01), Woodward
patent: 6613906 (2003-09-01), Davies et al.
patent: 2002/0177608 (2002-11-01), Dolitzky et al.
patent: 2004/0077683 (2004-04-01), Reddy et al.
patent: 1123438 (1982-05-01), None
patent: 1123439 (1982-05-01), None
patent: 2117892 (1993-10-01), None
patent: 2181089 (1994-12-01), None
patent: WO 93/21156 (1993-10-01), None
patent: WO 94/03170 (1994-02-01), None
patent: WO 94/09008 (1994-04-01), None
patent: WO 95/00480 (1995-01-01), None
patent: WO 96/26726 (1996-09-01), None
Bennett et al. “Concise chemical and technical dictionary” chem. Pub. p. 553 (1976).
Evans et al. “An introduction to crystal chemistry” Cambridge p. 296-298, 396 (1964).
See copies in parent.
Dean “Analytical chemistry handbook” McGraw-hill inc. (1955), p. 10.23-10.26.
Rouhi “The right stuff” Chem. Eng. News (2003) p. 32-35.
Engleson “Concise encyclopedia chemistry” (1944) p. 872-873.
Muzaffar et al. “Polymorphism and drug availability” J. Phar. 1(1) 59-66 (1979).
Jain et al. “Polymorphisom in pharmacey” Indian Drugs 23(g)315-329 (1986).
Doelker et al. “Crystalline modification . . . ” CA 138:209993 (2002).
Doelker et al. “Physicochemical behavior or active . . . ” CA 132:325872 (2000).
Otsuka et al. “Effect of polymorphic . . . ” Chem. Pharm. bull 47(6)852-856 (1999).
Akaishi et al. “Synthesis of diamond . . . ” CA 116:73144 (1992).
Rowland et al. “Clinical pharmacokinetics . . . ” Willaims and Wilkins, p. 123 (1995).
Dheronis “seminicro experimental organic chemistry” De Gratt, p. 4, 8 (1958).
Mascaselli L. “The isomerisim o erucic . . . ” CA 112:2214 (1918).
Niggli “New mineral syntheses” CA 16:21134 (1922).
Hohlweg et al. “The chemistry and biology . . . ” CA 30:50875 (1936).
Urazovskii “Molecular polymorphism” CA 45:51916 (1951).
Tauson et al. “Polymorphism of crystals and . . . ” CA 104:171677 (1986).
King et al. “4-diphenylmethyl-piperidine derivatives . . . ” CA 120:217287 (1994).
Henton et al. “Process for preparing anhydrous . . . ” CA 124:202030 (1996).
King et al. “Preparation of 4- . . . ” CA 127:50544 (1997).
Brittain “Polymorphism in pharmaceutical solids” Marcel Dekker Inc. p. 2, 185 (1999).
US Pharmacopia #23 national Formulary #18, p. 1843-1844 (1995).
Salole et al. “Effect of solvent deposition on . . . ” Derwent Acc. No. 86-22527 (1985).
Jalonen et al. “The crystal growth of carbamazepine . . . ” Derwent Acc. No. 90-02014 (1989).
Foks et al. “Effect of temperature and supersaturation . . . ” SciSearch 02857044 (1993).
Terao et al. “Second order nonliner . . . ” Pascal No. 92-0591460 (1990).
Office Action dated Feb. 18, 2004, in copending U.S. Appl. No. 10/386,812.
Physical Properties of Liquids, Encyclopedia Britannica Online (2004).
Distinction between Crystalline and Amorphous Solids, Encyclopedia Britannica Online (2004).
Internet page printouts of Hawley's Condensed Chemical Dictionary 1 (14thed. 2002) (definitions of amorphous and conformation).
Chan, K.Y. et al.; Direct Enantiomerica Separation of Terfenadine and Its Major Acid Metabolite by High-Performance Liquid Chromotography, and the Lack of Stereoselective Terfenadine Enantiomer Biotransformation in Man; CA 116:50726 (1992).
Henton, D. et al; Process for Preparing Anhydrous and Hydrate of Antihistaminic Piperidine Derivatives (Polymorphs and Pseudomorphs); CA 124:202030 (1996).
Morrison, R.T. & Boyd, R.N.; Organic Chemistry 75 (1973).
Office Action dated Jun. 11, 2004, in copending U.S. Appl. No. 10/160,883.
Office Action dated May 17, 2004, in copending U.S. Appl. No. 10/125,094 (now abandoned).
Office Action dated May 4, 2004, in copending U.S. Appl. No. 10/214,262.
Office Action dated Oct. 22, 2004, in copending U.S. Appl. No. 10/386,812.
Cheronis, N.D.; Semimicro Experimental Organic Chemistry, A Laboratory Manual 16-17 (J de Gratt 1958).
Bennett et al.; Concise Chemical and Technical Dictionary 553 (Chemical Publishing Co. 1974).
Burlage, H.M. et al.; Fundamental Principles and Processes of Pharmacy 464-67 (McGraw-Hill 2nd ed. 1949).
Cheronis, N.D.; Semimicro Experimental Organic Chemistry, A Laboratory Manual 31-42 (J de Gratt 1958).
Evans et al.; An Introduction to Crystal Chemistry 296-98, 396 (Cambridge 2nd Edition 1964).
Rawlins, E.A.; Bentley's Textbook of Pharmaceuticals 211-12 (8th ed. 1977).
Ulicky, L. et al.; Comprehensive Dictionary of Physical Chemistry 21 (Prentice Hall 1992).
Dean, J.A.; Analytical Chemistry Handbook 10.24 (McGraw Hill 1995).
European Search Report, dated Dec. 20, 2001.
PCT International Search Report, dated Aug. 10, 1995.
Canadian Office Action, with references cited therein, dated Nov. 6, 1998.
Argentine Search Report, dated Sep. 9, 1999.
Norwegian Search Report, dated Nov. 21, 2001.
Office Action dated Mar. 10, 2003, in co-pending U.S. Appli. No. 10/160,883.
Advisory Action dated Sep. 24, 2003, in co-pending U.S. Appl. No. 10/160.883.
Office Action dated Apr. 18, 2003, in co-pending U.S. Appl. No. 10/125,094.
Office Action dated Aug, 8, 2003, in co-pending U.S. Appl. No. 10/214,262.
Amon, U. et al.; Anti-allergic effects of H1-receptor antagonists on histamin-containing cells; 178(8) Dermatologische Monatsschrift 327-33 (1992).
Bailey, D.G. et al.; Effect of Grapefruit Juice and Naringin on Nisoldipine Pharmacokinetics; 54 Clinical Pharmacology & Therapeutics 589-94 (1993).
Bailey, D.G. et al.; Grapefruit Juice—Felodipine Interaction: Mechanism, Predictability, and Effect of Naringin, 53 Clinical Pharmacology & Therapeutics 637-42 (1993).
Bailey, D.G. et al.; Grapefruit Juice and Drugs: How Significant is the Interaction; 26(2) Clinical Pharmacokinetics 91-98 (1994).
Bailey, D.G. et al.; Grapefruit Juice—Felodipine Interaction: Reproducibility and Characterization with the Extended Release Drug Formulation; 40 Br. J. Clinical Pharmacology 135-40 (1995).
Baroody, F. et al.; The Effects of H1antihistamines on the Early Allergic Response; 63 Annals of Allergy 551-55 (1989).
Cantilena, L. et al.; Effect of Cimetidine and Ranitidine on the Pharmacokinetics and ECG Pharmacodynamics of Terfenadine; 53(2) Clinical Pharmacology & Therapeutics 161 (1993).
Charlesworth, E.N. et al.; Cutaneous Late-Phase Response in Food-Allergic Children and Adolescents with Atopic Dermatitis; 23 Clinical and Experimental Allergy 391-98 (1993).
Crumb, W.J. et al.; Blockade of Multiple Human Cardiac Potassium Currents by the Antihistamine Terfenadine: Possilbe Mechanism for Terfenadine-Associated Cardiotoxicit

Affiliated with

Also associated with

Rating

Processes for preparing anhydrous and hydrate forms of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Processes for preparing anhydrous and hydrate forms of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes for preparing anhydrous and hydrate forms of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3647655